Xiaofang Guo

525 total citations
35 papers, 388 citations indexed

About

Xiaofang Guo is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xiaofang Guo has authored 35 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xiaofang Guo's work include HER2/EGFR in Cancer Research (4 papers), Berberine and alkaloids research (4 papers) and Chemical Synthesis and Analysis (4 papers). Xiaofang Guo is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Berberine and alkaloids research (4 papers) and Chemical Synthesis and Analysis (4 papers). Xiaofang Guo collaborates with scholars based in China, Hong Kong and United States. Xiaofang Guo's co-authors include Xiaofei Zhu, Yong‐Su Zhen, Shenghua Zhang, Beibei Yang, Yue Shang, Hui Wang, Wenjuan Zhu, Qiyang He, Cheng Lu and Genxiang Mao and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and The FASEB Journal.

In The Last Decade

Xiaofang Guo

33 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofang Guo China 13 188 83 67 42 42 35 388
Qiang Zeng China 10 229 1.2× 133 1.6× 53 0.8× 78 1.9× 27 0.6× 22 588
Yun Su China 12 176 0.9× 49 0.6× 26 0.4× 26 0.6× 26 0.6× 27 345
Zakia Shinwari Saudi Arabia 15 293 1.6× 73 0.9× 25 0.4× 26 0.6× 16 0.4× 31 552
Patrik Strömberg Sweden 13 185 1.0× 36 0.4× 62 0.9× 18 0.4× 32 0.8× 20 456
Ben Lane United States 9 111 0.6× 68 0.8× 54 0.8× 25 0.6× 20 0.5× 10 422
Zixiang Zhang China 13 151 0.8× 179 2.2× 25 0.4× 55 1.3× 23 0.5× 25 424
Xiangli Meng China 14 378 2.0× 96 1.2× 39 0.6× 58 1.4× 12 0.3× 17 554
Rauf Onur Ek United States 15 149 0.8× 120 1.4× 29 0.4× 24 0.6× 49 1.2× 32 522

Countries citing papers authored by Xiaofang Guo

Since Specialization
Citations

This map shows the geographic impact of Xiaofang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Guo more than expected).

Fields of papers citing papers by Xiaofang Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Guo. The network helps show where Xiaofang Guo may publish in the future.

Co-authorship network of co-authors of Xiaofang Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofang Guo. A scholar is included among the top collaborators of Xiaofang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofang Guo. Xiaofang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Jianxin, Lei Feng, Qi Long, et al.. (2024). Mechanistic study of transcription factor Sox18 during heart development. General and Comparative Endocrinology. 350. 114472–114472. 1 indexed citations
2.
Zhang, Haoqi, Ruili Sun, Tingting Zhang, et al.. (2024). EX527, a sirtuins 1 inhibitor, sensitizes T-cell leukemia to death receptor-mediated apoptosis by downregulating cellular FLICE inhibitory protein. Cancer Biology & Therapy. 25(1). 2402588–2402588. 2 indexed citations
3.
Yu, Xiaolong, Xiaofang Guo, Xuan Zhou, et al.. (2024). From Perspective of Hippocampal Plasticity: Function of Antidepressant Chinese Medicine Xiaoyaosan. Chinese Journal of Integrative Medicine. 30(8). 747–758. 1 indexed citations
4.
Guo, Xiaofang, et al.. (2023). An active learning Gaussian modeling based multi-objective evolutionary algorithm using population guided weight vector evolution strategy. Mathematical Biosciences & Engineering. 20(11). 19839–19857. 1 indexed citations
5.
Zhang, Haoqi, et al.. (2022). Dual Inhibition of EGFR and IGF-1R Signaling Leads to Enhanced Antitumor Efficacy against Esophageal Squamous Cancer. International Journal of Molecular Sciences. 23(18). 10382–10382. 13 indexed citations
6.
Zhu, Xiaofei, et al.. (2020). The mitohormetic response as part of the cytoprotection mechanism of berberine. Molecular Medicine. 26(1). 10–10. 19 indexed citations
7.
Guo, Xiaofang, Zhou Zhang, Li Zheng, et al.. (2019). Developmental expression patterns of fosl genes in Xenopus tropicalis. Gene Expression Patterns. 34. 119056–119056. 2 indexed citations
8.
Zhu, Xiaofei, et al.. (2018). Combination of Berberine with Resveratrol Improves the Lipid-Lowering Efficacy. International Journal of Molecular Sciences. 19(12). 3903–3903. 35 indexed citations
9.
Guo, Xiaofang, et al.. (2018). Lapatinib in combination with paclitaxel plays synergistic antitumor effects on esophageal squamous cancer. Cancer Chemotherapy and Pharmacology. 82(3). 383–394. 14 indexed citations
10.
Zhu, Xiaofei, et al.. (2017). The Preconditioning of Berberine Suppresses Hydrogen Peroxide‐Induced Premature Senescence via Regulation of Sirtuin 1. Oxidative Medicine and Cellular Longevity. 2017(1). 2391820–2391820. 26 indexed citations
11.
12.
Hu, Xiao, et al.. (2015). Extramedullary hematopoiesis on 18F-FDG PET/CT in a patient with thalassemia and nasopharyngeal carcinoma: A case report and literature review. Journal of Cancer Research and Therapeutics. 11(4). 1034–1034. 4 indexed citations
13.
Liu, Jing, et al.. (2015). Microgranular variant of acute promyelocytic leukemia with der(17) ins(17;15): A case report and review of the literature. Experimental and Therapeutic Medicine. 10(3). 1009–1012. 2 indexed citations
14.
Li, Pengfei, Zijun Zhen, Zhuowei Liu, et al.. (2014). Effect of excision extension of primary tumors on local control and survival of stage IV neuroblastoma. Clinical Oncology and Cancer Research. 41(24). 1568–1572. 1 indexed citations
15.
Zhong, Genshen, Minna Wu, Xiaofang Guo, et al.. (2013). Small antibody fusion proteins with complementarity-determining regions and lidamycin for tumor targeting therapy. Oncology Letters. 5(4). 1183–1188. 2 indexed citations
16.
Guo, Xiaofang. (2012). Lapatinib, a dual inhibitor of EGFR and HER2, has synergistic effects with 5-fluorouracil on esophageal carcinoma. Oncology Reports. 27(5). 1639–45. 18 indexed citations
17.
Zhong, Genshen, et al.. (2012). Antitumor activities of dFv-LDP-AE: An enediyne-energized fusion protein targeting tumor-associated antigen gelatinases. Oncology Reports. 28(4). 1193–1199. 7 indexed citations
18.
Guo, Xiaofang, Xiaofei Zhu, Yue Shang, Shenghua Zhang, & Yong‐Su Zhen. (2010). A Bispecific Enediyne-Energized Fusion Protein Containing Ligand-Based and Antibody-Based Oligopeptides against Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Shows Potent Antitumor Activity. Clinical Cancer Research. 16(7). 2085–2094. 38 indexed citations
19.
Lu, Cheng, Mei Chong, Weiwei Fan, et al.. (2007). Molecular cloning, characterization, and developmental expression of foxp1 in zebrafish. Development Genes and Evolution. 217(10). 699–707. 15 indexed citations
20.
Guo, Xiaofang & Haiyan Yan. (2005). Dof protein and Dof transcription factor family in plants. Chih Wu Sheng Li Hsueh T'ung Hsun. 41(4). 419–423. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiang Zeng Breakdown of academic impact, for papers by Yun Su Breakdown of academic impact, for papers by Zakia Shinwari Breakdown of academic impact, for papers by Patrik Strömberg Breakdown of academic impact, for papers by Ben Lane Breakdown of academic impact, for papers by Zixiang Zhang Breakdown of academic impact, for papers by Xiangli Meng Breakdown of academic impact, for papers by Rauf Onur Ek
Rankless by CCL
2026